Zusammenfassung: Vorinkubation menschlicher Hautfibroblasten in Gegenwart von 10~6-10~~5 mol/1 Glucocorticoiden (Dexamethason) führt zu einer konzentrations-und zeitabhängigen Zunahme der Rezeptorvermittelten Aufnähme von [ 125
, 2 ) activity has been fibroblasts are known to initiate a suppression of observed in various Systems in vivo and in vitro ' (2) (3) (4) and is assumed to reflect the conversion of l ) Abbreviations. LDL, low density lipoprotein; HMG-CoA, HMG-CoA into mevalonic acid äs the rate-limiting 3-hydroxy-3-methylglutaryl-CoA; SDS, sodiüm dodecyl step j n \fa COU rse of cholesterogenesis. However, Thus, in HeLa cells the increased cholesterol synthesis from acetate after serum removal from the medium was partially suppressed by dexamethasone, but this suppression was not accompanied by an expected decrease in activity of HMG-CoA reductase (5). Also, in a variety of cell lines grown in the presence of dexamethasone the incorporation of acetate into cellular cholesterol was suppressed while HMG-CoA reductase activity was either elevated or remained unchanged (6, 7).
The glucocorticoid effect seems to depend on the sensitivity of the cell line and the glucocorticoid concentration. Thus, Brown & Goldstein (4) have shown that growth of fibroblasts in the presence of cortisol had no effect on HMG-CoA reductase activity even at l O" 5 mol/1 concentration while in HeLa and HTC cells (6) glucocorticoids were effective in the induction of HMG-CoA reductase at concentrations ranging from 10-6 mol/1 (6) to IQ-8 mol/1 (5). Moreover, there was a demoEßtrated parallel between the magnitude of enzyme induction and glucocorticoid potency, so that the order of activity was dexamethasone > prednisolone > cortisol (5).
The criteria used in previous studies on the influence of glucocorticoids on cholesterol metabolism were (I) the incorporation of [ The presented data may be important not only in terms of the further understanding of the mechanism of action of glucocorticoids but could also contribute to a more rational use of steroid analogues äs chemotherapeutical agents. We have therefore examined not only the physiological concentrations of glucocorticoids but also their therapeutical doses. 
Materials and Methods

Materials
Cells
Normal human fibroblasts were gfown from the skin explant of a normal infant and were used för ihcubation experiments between the third and eight passäges. Incubation conditions are described in the corresponding figures and tables.
Assays
The binding, internalisation and degradation assays of [ 125 I]LDL were performed at 37 °C, using the method of Brown & Goldstein (4). Bindung and uptake of 125 I-labelled epidermal growth factor were determined according to Kita et al. (11) . Protein was determined by the method of Kaltwasser et al, (12) .
Lipid analyses
Lipids were extracted from the cell with Chloroform: methanol (2+ 1 by volume) and separated into individual lipid classes on silica G plates äs described previously (13) . Trace amounts of diglycerides were elimmated frönt the cholesterol fraction by digitonin precipitation.
Antibodies against LDL receptor
The LDL receptor from bovine adrenal cortex membranes was isolated and purified according to Schneider et al. (14) . Antibodies against the LDL receptor were produced in rabbits according to Kita et ai. (11) . Aiitibodies from goat directed against rabbit -globulins were a gift from Dr. B. Voss, Institute of Arteriosclerosis Research, Münster. Rabbit antibodies directed against human placentäl cathepsin D (15) were a gift from Dr. Gieselmann in the authors' institute. After extensive washings the cells were lysed, LDL receptor was precipitated from the cell lysate by specific antibodies and analysed by SDS electrophoresis äs described (9) . 
LDL receptor synthesis
Results
Preincubation of monolayers of human skin fibroblasts with dexamethasone causes a concentration-dependent increase (up to 50%) of receptor-mediated binding ( fig. 1 ), internalization and degradation (not shown) of LDL, compared with cell cultures preincubated without glucocorticoids or in the presence of oestradiol-17 (tab. 1). The effect on LDL binding is detectable after a short lag phase and reaches maximal values after preincubation of the cells in the presence of effective steroids for 48 hours (tab. l, fig. 2 ).
The glucocorticoid-induced increase of LDL receptor activity was correlated with a Stimulation of LDL receptor synthesis s indicated by a higher rate of incorporation of [ The glucocorticoid-enhanced LDL receptor activity and synthesis was fo nd to be glucocorticoid-specific but not LDL receptor-specific. Thus, after preincubation of the cells with 12 μπιοΐ/ΐ dexamethasone the receptor mediated binding and internalisation of [ In our fibroblast culture Systems glucocorticoids were ineffective at physiolögical concentration (10~~7 mol/1). This confinns earlier firidings that human skin fibroblasts seem to be less sensitive towards glucocorticoids than pther cell lines. Whereas in HeLa (6, 7) and HTC (6) fig. 3) , but it appears doubtful whether this effect reflects a physiolögical action of glucocorticoids. The fact that the dexamethasoneinduced increase of LDL receptor synthesis could be suppressed when the cells were incubated with a combination of dexamethasone and 25-hydroxycholesterol suggests that dexamethasone in higher concentrations prevents the intracellular formation of oxygenated cholesterol derivatives which are known to be powerful inhibitors of cholesterol biosynthesis in various types of cells in culture and in vivo (17) . Such oxygenated sterols, for example 24,25-oxidolanosterol (18) are generated from squalene 2,3:22:23-dioxide, which can be metabolized into compounds more polar than cholesterol. Squalene 2,3:22:23-dixoide is not a normal intermediate of cholesterol biosynthesis, but is formed from squalene 2,3-epoxide (an obligatory precursor of cholesterol) when the enzyme squalene 2,3-epoxide cyclase is partially inhibited (19) . A complete Inhibition of squalene 2,3 epoxide cyclase, however, would prevent the formatiön of oxygenated sterols and hence lessen the inhibition of HMG-CoA reductase, with the resült that cholesterol and LDL receptor synthesis are stimulated.
The glucocorticoid-induced increase of LDL receptor synthesis was shown to exhibit relative specificity.
Thus, on the one band the rate of synthesis of a lysosomal marker enzyme, cathepsin D, was not influenced and the synthesis of total cell protein was not elevated by dexamethasone. On the other hand not only the endocytosis uptake of LDL but also the receptor-mediated endocytosis of the epidermal growth factor was enhanced by dexamethasone. This is in accordance with findings of Sadig et al. (15) , who observed a betamethasone-induced increase of foetal pulmonary epidermal growth factor. Froin these results it is concluded that glucocorticoids in the concentrations used effect a selective augmentation in the synthesis of glucocorticoid dependent proteins, but do not exert a general stimulating effect on protein biosynthesis. The elevated incorporation of [2- 
